Skip to main content
. 2021 Jan 5;6:10. doi: 10.21037/tgh.2020.01.07

Table 4. Univariate and multivariate regression analysis of risk factors for postoperative Clavien IV complications and 30 days mortality.

Risk factors Univariate analysis Multivariate analysis
Clavien IV Mortality Clavien IV Mortality
uOR (95% CI) P value uOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value
Frailty groups
   No frailty ref ref ref ref
   Low frailty 1.73 (1.37–2.19) <0.001 2.99 (1.89–4.77) <0.001 1.51 (1.18–1.94) 0.001 1.94 (1.18–3.19) 0.009
   Intermediate frailty 2.89 (2.26–3.69) <0.001 5.18 (3.24–8.28) <0.001 2.4 (1.84–3.13) <0.001 3.01 (1.79–5.05) <0.001
   Frail 5.1 (3.94–6.59) <0.001 9.98 (6.24–15.97) <0.001 3.88 (2.91–5.16) <0.001 5.12 (3.03–8.65) <0.001
Age ≥65 2.05 (1.72–2.43) <0.001 4.615 (3.26–6.53) <0.001 1.43 (1.19–1.75) <0.001 3.08 (2.09–4.53) <0.001
Gender, male 1.4 (1.18–1.65) <0.001 1.24 (0.95–1.63) 0.116 1.2 (1.01–1.44) 0.042
BMI ≥30 1.07 (0.88–1.29) 0.49 0.69 (0.49–0.97) 0.031 0.87 (0.61–1.25) 0.451
Weight loss >10% 1.26 (1.01–1.58) 0.04 1.76 (1.27–2.45) 0.001 1.32 (1.04–1.68) 0.022 2.03 (1.41–2.93) <0.001
Chemotherapy 0.77 (0.49–1.21) 0.26 1.99 (1.19–3.33) 0.008 2.38 (1.38–4.1) 0.002
Steroid use 2.8 (1.95–4.03) <0.001 2.84 (1.66–4.84) <0.001 2.52 (1.72–3.71) <0.001 2.30 (1.28–4.13) 0.005
HCT <30 2.11 (1.74–2.57) <0.001 2.29 (1.69–3.1) <0.001 1.93 (1.57–2.37) <0.001 1.92 (1.37–2.68) <0.001
Type of gastrectomy
   Distal gastrectomy ref ref ref
   Total gastrectomy 1.26 (1.05–1.53) 0.015 0.694 (0.69–1.32) 0.796 1.42 (1.16–1.73) <0.001
   Gastrectomy with pouch formation 1.21 (0.79–184) 0.39 0.84 (0.39–1.82) 0.664 1.37 (0.87–2.15) 0.171

aOR, adjusted odds ratios; uOR, unadjusted odds ratios.